The analyst expects the soft tissue repair market is projected to reach USD 17.2 Billion by 2027 from USD 13.6 Billion in 2022, at a CAGR of 4.7% during the forecast period. Growth in this market is mainly driven by increasing aging population and obesity rate, growing incidence of sports injuries, strong focus on R&D leading to the launch of technologically advanced products, and increasing volume of surgeries and growing prevalence of severe trauma injuries. An unfavorable reimbursement scenario and high price of soft tissue repair products and the rising cost of surgical procedures are the key factors restraining the growth of the market. In this report, the soft tissue repair market is segmented on the basis of product, application, end-user, and region. In this report, the soft tissue repair market is segmented on the basis of product, application, end-user, and region.
Based on product, soft tissue repair market is segmented into tissue patch/mash and laparoscopic instrument injectors. In 2021, Tissue Patch/Mesh accounted for the larger share of 91.9% of the soft tissue repair market. This product segment is projected to reach USD 15,892.3 million by 2027 from 12,547.2 million in 2022, at a CAGR of 4.8% during the forecast period. The large share of this segment is attributed to the increasing use of synthetic Mesh across different types of orthopedic surgeries as they reduce surgical time.
Based on application type, the soft tissue repair market is segmented into Hernia Repair, Dural Repair, Vaginal Sling Procedures, Skin Repair, Orthopedic repair, Dental repair, Breast Reconstruction Repair, and other applications. In 2021, the hernia repair is estimated to account for the largest share of 26.5% of the soft tissue repair market, by application. The increasing incidence of hernia cases, sports injuries and the growing prevalence of lifestyle disorders, such as arthritis, osteoporosis, and obesity (leading to orthopedic problems), are some of the major factors responsible for the growth in the number of soft tissue repair surgeries performed globally.
Based on end-users, the soft tissue repair market is segmented into hospitals, clinics, and other end-users (ambulatory surgery centers, emergency care centers, burn care centers, and research institutes). The hospitals segment accounted for the largest share of 93.3% of the soft tissue repair market in 2021. This is primarily attributed to the increasing number of surgeries taking place across the globe due to the rising geriatric population and the incidence of various diseases. Moreover, the increasing need to control blood loss and achieve efficient hemostasis and wound closure in trauma cases, injuries, or surgical procedures is leading to the increasing adoption of soft tissue repair products by surgeons.
On the basis of region, the soft tissue repair market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of 43.5% of the soft tissue repair market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of the North American market is attributed to the presence of an advanced healthcare system in the region, high and growing number of surgical procedures, higher adoption of advanced products, and the presence of several leading market players in the US.
The market study covers the soft tissue repair market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product, by application, by end-user, and by region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Prominent players in the soft tissue repair market include Smith & Nephew Plc. (UK), Arthrex, Inc. (US), Stryker Corporation (US), Johnson & Johnson (US), Medtronic plc (IE), LifeNet Health, Inc. (US), Becton, Dickinson and Company (US), Integra LifeSciences Corporation (US), CryoLife, Inc. (US), Organogenesis Inc. (US), Zimmer Biomet (US), Baxter International, Inc. (US), ACell Inc. (US), Tissue Regenix Group Plc (UK) and Aroa Biosurgery Ltd. (NZ). These players have adopted various growth strategies such as acquisition, product launches, and expansion to increase their presence and reach in the soft tissue repair market.
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the soft tissue repair market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.
Tissue Patched/Mashes accounted for the largest share in the soft tissue repair market by Product type
Based on product, soft tissue repair market is segmented into tissue patch/mash and laparoscopic instrument injectors. In 2021, Tissue Patch/Mesh accounted for the larger share of 91.9% of the soft tissue repair market. This product segment is projected to reach USD 15,892.3 million by 2027 from 12,547.2 million in 2022, at a CAGR of 4.8% during the forecast period. The large share of this segment is attributed to the increasing use of synthetic Mesh across different types of orthopedic surgeries as they reduce surgical time.
Hernia Repair accounted for the largest share in the soft tissue repair market by Application
Based on application type, the soft tissue repair market is segmented into Hernia Repair, Dural Repair, Vaginal Sling Procedures, Skin Repair, Orthopedic repair, Dental repair, Breast Reconstruction Repair, and other applications. In 2021, the hernia repair is estimated to account for the largest share of 26.5% of the soft tissue repair market, by application. The increasing incidence of hernia cases, sports injuries and the growing prevalence of lifestyle disorders, such as arthritis, osteoporosis, and obesity (leading to orthopedic problems), are some of the major factors responsible for the growth in the number of soft tissue repair surgeries performed globally.
Hospital segment accounted for the largest share in the soft tissue repair market by End-user
Based on end-users, the soft tissue repair market is segmented into hospitals, clinics, and other end-users (ambulatory surgery centers, emergency care centers, burn care centers, and research institutes). The hospitals segment accounted for the largest share of 93.3% of the soft tissue repair market in 2021. This is primarily attributed to the increasing number of surgeries taking place across the globe due to the rising geriatric population and the incidence of various diseases. Moreover, the increasing need to control blood loss and achieve efficient hemostasis and wound closure in trauma cases, injuries, or surgical procedures is leading to the increasing adoption of soft tissue repair products by surgeons.
North America segment accounted for the largest share in the soft tissue repair market by Region
On the basis of region, the soft tissue repair market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of 43.5% of the soft tissue repair market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of the North American market is attributed to the presence of an advanced healthcare system in the region, high and growing number of surgical procedures, higher adoption of advanced products, and the presence of several leading market players in the US.
Research Coverage
The market study covers the soft tissue repair market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product, by application, by end-user, and by region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Market Players
Prominent players in the soft tissue repair market include Smith & Nephew Plc. (UK), Arthrex, Inc. (US), Stryker Corporation (US), Johnson & Johnson (US), Medtronic plc (IE), LifeNet Health, Inc. (US), Becton, Dickinson and Company (US), Integra LifeSciences Corporation (US), CryoLife, Inc. (US), Organogenesis Inc. (US), Zimmer Biomet (US), Baxter International, Inc. (US), ACell Inc. (US), Tissue Regenix Group Plc (UK) and Aroa Biosurgery Ltd. (NZ). These players have adopted various growth strategies such as acquisition, product launches, and expansion to increase their presence and reach in the soft tissue repair market.
A breakdown of the primary participants (supply-side) for the soft tissue repair market referred to for this report is provided below:
- By Company Type: Tier 1 - 5%, Tier 2 - 15%, and Tier 3 - 80%
- By Designation: C-level - 45%, Director Level - 25%, and Others - 30%
- By Region: North America - 36%, Europe - 26%, Asia Pacific - 21%, Latin America - 10%, and Middle East and Africa - 7%
Key Benefits of Buying the Report
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the soft tissue repair market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.
Table of Contents
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Soft Tissue Repair Market, by Product
7 Soft Tissue Repair Market, by Application
8 Soft Tissue Repair Market, by End-user
9 Soft Tissue Repair Market, by Region
10 Competitive Landscape
11 Company Profiles
12 Appendix
Companies Mentioned
- Acell Inc.
- Acera Surgical Inc.
- Aroa Biosurgery Ltd.
- Arthrex Inc.
- Baxter International, Inc.
- Becton, Dickinson & Company
- Betatech Medical
- Biocer Entwicklungs-GmbH
- Conmed Corporation
- Cryolife Inc.
- Integra Lifesciences Holdings Corporation
- Isto Biologics
- Johnson & Johnson
- Lifenet Health Inc.
- Medtronic plc.
- Meril Life Sciences Pvt. Ltd.
- MiMedx
- Organogenesis Inc.
- Orthocell Ltd.
- RTI Surgical
- Samyang Holdings Corporation
- Smith & Nephew plc
- Stryker Corporation
- Tissue Regenix Group plc
- Zimmer Biomet
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 222 |
Published | March 2022 |
Forecast Period | 2022 - 2027 |
Estimated Market Value ( USD | $ 13.6 Billion |
Forecasted Market Value ( USD | $ 17.2 Billion |
Compound Annual Growth Rate | 4.7% |
Regions Covered | Global |
No. of Companies Mentioned | 25 |